M H Hasanova

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM In real life to evaluate the effectiveness and safety of apixaban with double antiplatelet therapy for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation and the recent episode of acute coronary syndrome without ST segment elevation. MATERIALS AND METHODS 8 patients with atrial fibrillation and the recent(More)
  • 1